Iron Chelation Therapy with Deferasirox Results in Recovery of Hematopoiesis in a Child with Aplastic Anemia

Jae Wook LeeDivision of Hematology and Oncology, Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea

, MD,

Pil-Sang JangDivision of Hematology and Oncology, Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea

, MD, PhD,

Nack-Gyun ChungDivision of Hematology and Oncology, Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea

, MD, PhD,

Bin ChoDivision of Hematology and Oncology, Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, KoreaCorrespondence[email protected]

, MD, PhD,

Dae-Chul JeongDivision of Hematology and Oncology, Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea

, MD, PhD &

Hack-Ki KimDivision of Hematology and Oncology, Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea

, MD, PhD , MD

REFERENCES

Cappellini MD, Taher A. Deferasirox (Exjade) for the treatment of iron overload. Acta Haematol. 2009;122:165–173.
PubMed Web of Science ®Google Scholar
Nishiuchi T, Okutani Y, Fujita T, Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patient with myelodysplastic syndrome. Int J Hematol. 2010;91:333–335.
PubMedGoogle Scholar
Di Tucci AA, Murru R, Alberti D, Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670). Eur J Haematol. 2007;78:540–542.
PubMed Web of Science ®Google Scholar
Taher AT, Musallam KM, Koussa S, Inati A. Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy. Ann Hematol. 2009;88:1263–1264.
PubMedGoogle Scholar
Oliva EN, Ronco F, Marino A, Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patients. Transfusion. 2010;50:1568–1570.
PubMed Web of Science ®Google Scholar
Breccia M, Loglisci G, Salaroli A, Deferasirox treatment interruption in a transfusion-requiring myelodysplastic patient led to loss of erythroid response. Acta Haematol. 2010;124:46–48.
PubMedGoogle Scholar
International Agranulocytosis and Aplastic Anemia Study. Incidence of aplastic anemia: the relevance of diagnostic criteria. Blood. 1987;70:1718–1721.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Iron Chelation Therapy with Deferasirox Results in Recovery of Hematopoiesis in a Child with Aplastic Anemia

REFERENCES

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Iron Chelation Therapy with Deferasirox Results in Recovery of Hematopoiesis in a Child with Aplastic Anemia

REFERENCES

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date